VigiCarib is a voluntary regional system for CARICOM states to report medicines related adverse events (adverse drug reactions (ADRs)) and substandard and falsified (SF) products. Medicines safety and monitoring systems are often limited in the individual small states of CARICOM, and the rationale for a regional approach is that with pooling of resources, sharing of information, and coordination of activities, there will be efficiencies of scale that can lead to stronger systems overall.

Supporting Global Vigilance and Post Market Surveillance

VigiCarib network facilitates the submission of reports of suspected adverse drug reactions (ADRs), and reports of quality issues to international monitoring systems of the WHO Programme for International Drug Monitoring at Uppsala Monitoring Centre, and to the WHO Global Surveillance and Monitoring System. This assists Member States with limited human resources to contribute to global vigilance, and to receive information on international and regional trends in reporting.

Reporting Forms

Reports of suspected adverse drug reactions, and reports of suspect substandard / falsified / unregistered medicines may be submitted confidentially to VigiCarib using any of the following methods :

The VigiCarib Reporting form in Word

   VigiCarib Vaccine AEFI Form at:

   The VigiCarib Online Form at:; or

   E-Reporting (for reports of suspected adverse drug reactions from St Vincent and the Grenadines):

VigiCarib news

  • View latest VigiCarib news here
  • View Uppsala Report featuring Vigicarib Newsletter here